Antimicrobial peptides (AMPs) have gained much attention for their potential to treat diseases related to bacterial and viral infections, specifically against pathogens that have become multidrug resistant (MDR), extensively drug resistant (XDR), or pan-drug resistant (PDR) [1,2]. Here, ADSL is linked to viral infectious disease.